Intravenous Buprenorphine Reversed Opioid-Induced Respiratory Depression Without Precipitating Withdrawal in Emergency Department Patients
In this case series patients who received intravenous buprenorphine after an acute opioid overdose had some clinical improvement and did not develop buprenorphine precipitated withdrawal. Further research should be performed to determine the safety and efficacy of intravenous buprenorphine as an opioid overdose reversal agent.
Authors
- Anthony Spadaro (ORCID: https://orcid.org/0000-0002-0941-4651)
- Cynthia Santos (ORCID: https://orcid.org/0000-0003-2720-8912)
- Jaclyn Scalgione
- Nicholas Imperato
Institutions
- Rutgers, The State University of New Jersey (US)
Publication Details
- Journal
- Journal of Studies on Alcohol and Drugs
- Published
- 2025-10-15
- DOI
- https://doi.org/10.15288/jsad.25-00263
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00